Package 58602-832-83

{"route": ["ORAL"], "spl_id": "0287563f-3472-401d-b95f-9694258def17", "openfda": {"unii": ["9TN87S3A3C", "6V9V2RYJ8N"], "rxcui": ["1367426"], "spl_set_id": ["10a8a74b-11d1-490e-87e7-d705fe0e7602"], "manufacturer_name": ["Aurohealth LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (58602-832-67)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "58602-832-67", "marketing_start_date": "20220601"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (58602-832-83)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "58602-832-83", "marketing_start_date": "20220601"}], "brand_name": "Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache", "product_id": "58602-832_0287563f-3472-401d-b95f-9694258def17", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "58602-832", "generic_name": "Naproxen Sodium and Pseudoephedrine Hydrochloride", "labeler_name": "Aurohealth LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA211360", "marketing_category": "ANDA", "marketing_start_date": "20220601", "listing_expiration_date": "20261231"}